Evidence map›Paper›PMID 17704826›Full record

ReviewBritish journal of pharmacology2007

Endocannabinoids and the haematological system.

M D Randall

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Cannabis and Paternal Epigenetic Inheritance.International journal of environmental research and public health · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Disease-Specific Derangement of Circulating Endocannabinoids andInternational journal of molecular sciences · 2020
    Article
  8. Recurrent priapism in the setting of cannabis use.Journal of cannabis research · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Cannabinoids and their actions.British journal of pharmacology · 2007
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

M D RandallSchool of Biomedical Sciences, University of Nottingham Medical School, Nottingham, UK. michael.randall@nottingham.ac.uk
University of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocannabinoids are blood borne and may also be secreted by the endothelium. Accordingly, there has been interest in the interactions between (endo)cannabinoids and blood cells. There is certainly evidence that (endo)cannabinoids may promote platelet activation, indicating that they may be thrombogenic. Platelets are involved both in the metabolism and release of endocannabinoids, and so it is possible that their circulating levels may be regulated by platelets. This process is altered in disease states such that platelet-derived endocannabinoids contribute towards hypotension in cardiovascular shock. Not only may endocannabinoids regulate platelet function and possibly lead to thrombogenesis, but they may also influence haematopoiesis. Given these emerging roles, the aim of this review is to examine the interactions between cannabinoids and blood.

Indexed as

EndocannabinoidsAnimalsAtherosclerosisBlood PlateletsCannabinoid Receptor ModulatorsEndothelium, VascularErythrocytesHematopoiesisHumansModels, BiologicalPlatelet ActivationCannabinoid Receptor ModulatorsEndocannabinoids

Identifiers

PMID17704826
PMCPMC2190025
OpenAlexW2137127936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.